Log In
BCIQ
Print this Print this
 

CERC-501 (formerly LY2456302)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionKappa opioid receptor (KOR; OPRK1) antagonist
Molecular Target Kappa opioid receptor (KOR) (OPRK1)
Mechanism of ActionKappa opioid receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/20/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today